Wei Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Xiao has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Yong Tang
GuangDong Engineering Technology Research Center of Antibody Drug and Immunoassay, Department of Biological Sciences and Biotechnology, College of Life Science and Technology, Jinan University, Guangzhou, China
3 shared publications Cong Lin
2 shared publications- Hui Chen
Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine School of Chemistry South China Normal University Guangzhou People's Republic of China
2 shared publications Jiting Deng
2 shared publicationsQian Zhao
2 shared publicationsShibo Shang
2 shared publications
Latest Publications
- 31 March 2020
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 8 (20) , 6861-6868
A MoS2 nanoflower and gold nanoparticle-modified surface plasmon resonance biosensor for a sensitivity-improved immunoassay
Herein, MoS2 nanoflowers were deposited on a plasmonic interface for a sensitivity-enhanced immunoassay by increasing the amount of the loaded antibodies.
- 31 March 2020
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 8 (20) , 6861-6868
A MoS2 nanoflower and gold nanoparticle-modified surface plasmon resonance biosensor for a sensitivity-improved immunoassay
Herein, MoS2 nanoflowers were deposited on a plasmonic interface for a sensitivity-enhanced immunoassay by increasing the amount of the loaded antibodies.
- 20 August 2019
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 11 (37) , 4814-4821
The combined detection of ovarian cancer biomarkers HE4 and CA125 by a fluorescence and quantum dot dual-signal immunoassay
Detection of the biomarkers human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) is an important parameter for ovarian cancer diagnosis and follow-up. For this reason, our study aimed to develop an immunological detection method for simultaneous detection of multiple ovarian cancer biomarkers based on a dual-signal system. The dual-signal system consists of quantum dot nanospheres (QDNBs) and fluorescent nanoparticles (FNPs) that emit different wavelengths of fluorescence under different excitation light. The HE4 and CA125 detection antibodies were conjugated with FNPs and QDNBs to form signal complexes, which produce a signal proportional to the concentration of HE4 and CA125. This dual-signal immunoassay was applied to human serum samples to detect HE4 and CA125 levels and compare them using an electrochemiluminescence (ECL) assay. The linear range of the assay was determined to be 1.25–20 ng mL−1 for HE4, and 9.4–200 U mL−1 for CA125. Comparison of 25 human serum samples subjected to the ECL assay resulted in impressive correlation coefficients of 0.91 and 0.96 for HE4 and CA125, respectively. A quantitative method for detecting HE4 and CA125 was successfully established. Preliminary clinical sample analysis showed that the dual-signal immunoassay has a strong clinical value in the screening and diagnosis of ovarian cancer.
- 20 August 2019
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 11 (37) , 4814-4821
The combined detection of ovarian cancer biomarkers HE4 and CA125 by a fluorescence and quantum dot dual-signal immunoassay
Detection of the biomarkers human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) is an important parameter for ovarian cancer diagnosis and follow-up. For this reason, our study aimed to develop an immunological detection method for simultaneous detection of multiple ovarian cancer biomarkers based on a dual-signal system. The dual-signal system consists of quantum dot nanospheres (QDNBs) and fluorescent nanoparticles (FNPs) that emit different wavelengths of fluorescence under different excitation light. The HE4 and CA125 detection antibodies were conjugated with FNPs and QDNBs to form signal complexes, which produce a signal proportional to the concentration of HE4 and CA125. This dual-signal immunoassay was applied to human serum samples to detect HE4 and CA125 levels and compare them using an electrochemiluminescence (ECL) assay. The linear range of the assay was determined to be 1.25–20 ng mL−1 for HE4, and 9.4–200 U mL−1 for CA125. Comparison of 25 human serum samples subjected to the ECL assay resulted in impressive correlation coefficients of 0.91 and 0.96 for HE4 and CA125, respectively. A quantitative method for detecting HE4 and CA125 was successfully established. Preliminary clinical sample analysis showed that the dual-signal immunoassay has a strong clinical value in the screening and diagnosis of ovarian cancer.
- 13 May 2019
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 4 (6) , 1508-1514
A Rapid, Simple, and Low-Cost CD4 Cell Count Sensor Based on Blocking Immunochromatographic Strip System
The counting of CD4+ T lymphocytes (CD4 cells) is a critical test for evaluating the immune function of HIV-infected peoples and tumor patients. A rapid, simple, accurate and low-cost CD4 cell counting method as a diagnostic tool is increasingly required in clinic. We designed and developed a novel fluorescent immunochromatographic strips (ICS) system based on blocking principle for counting CD4 cells. The strategy of this system is to count CD4 cells indirectly, by measuring the free CD4 antibodies that were not bound by CD4 cells. The fluorescent antibodies bound to CD4 cells were blocked at the filter pads, resulting in a de-crease in fluorescence of free CD4 antibodies measured. The number of CD4 cells was inversely related to the fluorescence inten-sity. The CD4 count-ICSs exhibited a quasilinear response (R2=0.96) to logarithmic CD4 cell concentrations in PBMC samples in the range of 50 to 1000 cells/μL. In addition, the CD4 count-ICSs reliably quantified CD4 cells in whole blood samples, where the assay exhibited a linear correlation (R2=0.976) readout for CD4 cell concentrations ranging from 100 to 800 cells/μL. To validate the clinical applicability of this method, 54 blood samples were measured, the detection results showed a high correlation (R2> 0.97) with the flow cytometry (FCM) analysis. The fluorescent ICSs can be used to count CD4 cells in blood samples, which have a high coincidence rate with FCM analysis, therefore, the CD4 count ICS system is an excellent candidate method for CD4 cell counting in resource-limited settings.
- 13 May 2019
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 4 (6) , 1508-1514
A Rapid, Simple, and Low-Cost CD4 Cell Count Sensor Based on Blocking Immunochromatographic Strip System
The counting of CD4+ T lymphocytes (CD4 cells) is a critical test for evaluating the immune function of HIV-infected peoples and tumor patients. A rapid, simple, accurate and low-cost CD4 cell counting method as a diagnostic tool is increasingly required in clinic. We designed and developed a novel fluorescent immunochromatographic strips (ICS) system based on blocking principle for counting CD4 cells. The strategy of this system is to count CD4 cells indirectly, by measuring the free CD4 antibodies that were not bound by CD4 cells. The fluorescent antibodies bound to CD4 cells were blocked at the filter pads, resulting in a de-crease in fluorescence of free CD4 antibodies measured. The number of CD4 cells was inversely related to the fluorescence inten-sity. The CD4 count-ICSs exhibited a quasilinear response (R2=0.96) to logarithmic CD4 cell concentrations in PBMC samples in the range of 50 to 1000 cells/μL. In addition, the CD4 count-ICSs reliably quantified CD4 cells in whole blood samples, where the assay exhibited a linear correlation (R2=0.976) readout for CD4 cell concentrations ranging from 100 to 800 cells/μL. To validate the clinical applicability of this method, 54 blood samples were measured, the detection results showed a high correlation (R2> 0.97) with the flow cytometry (FCM) analysis. The fluorescent ICSs can be used to count CD4 cells in blood samples, which have a high coincidence rate with FCM analysis, therefore, the CD4 count ICS system is an excellent candidate method for CD4 cell counting in resource-limited settings.